• Total sales of $111.0 million, marginally down 0.2% vs prior year
• Gross profit margins improved to 63.0%, up from 62.1% in prior year
• Net Profit after Tax expected to be in the range of $10.0 million to $10.4 million

SDI Limited, a leading dental technology company, has provided a trading update for the twelve months ended 30 June 2025. The company reported total sales of $111.0 million, marginally down 0.2% compared to the prior corresponding period. In local currencies, European sales were up 7.2% and Brazil up 9.9%, but these regional gains were partially offset by weaker direct export sales in the Middle East and Asia, as well as continuing declines in Amalgam sales, down 20.4% on the prior year and now representing 13.3% of total sales. Gross profit margins improved to 63.0%, up from 62.1% in the prior year, driven by ongoing production efficiencies and product mix. Operating expenses remained well managed despite sustained inflationary pressures, especially in employment costs. Net Profit after Tax (NPAT) is expected to be in the range of $10.0 million to $10.4 million, compared to $10.4 million for the prior corresponding period. The company also provided an update on the Montrose project, with construction tenders received and the planning permit approval progressing well. The Board has resolved that the project will be fully funded by a combination of sale and lease back of the current Bayswater premises and debt.

Net Profit after Tax (NPAT) is expected to be in the range of $10.0 million to $10.4 million for the financial year ended 30 June 2025.